Notably, we constructed patient-derived ccRCC organoids and demonstrated that YOD1 silencing significantly accelerated organoid growth, further underscoring the critical tumor-suppressive function of YOD1 in ccRCC. This evidence concerns the gene YOD1 and nonpapillary renal cell carcinoma.